Table 1.
Percent inhibition and IC50 of manzamine-derived compounds 152–166.
| |||||||
|---|---|---|---|---|---|---|---|
| Compound | R1 | R2 | R3 | R4 | X-Y | GSK3β Inhibition at 25 µM |
GSK3β IC50 |
| 152 | OTs | H | H |
|
HC=CH | 80.4 | n.d. a |
| 153 | OMe | H | Me |
|
HC=CH | 72.4 | n.d. a |
| 154 | OEt | H | Et |
|
HC=CH | 78.0 | 10.4 |
| 155 | O-i-But | H | i-But |
|
HC=CH | 24.2 | n.d. a |
| 156 | H | H | (CH2)11CH3 |
|
HC=CH | 0 | n.d. a |
| 157 | H | H | t-BuOCOMe |
|
HC=CH | 3 | n.d. a |
| 158 | H | H | H |
|
HC=CH | 88.4 | n.d. a |
| 159 | OH | H | H |
|
(CH2)2 | 29.0 | n.d. a |
| 160 | OH | H | H |
|
HC=CH | 30.0 | n.d. a |
| 161 | H | H | H |
|
(CH2)2 | 0 | n.d. a |
| 162 |
|
H | H |
|
HC=CH | 78.8 | 8.5 |
| 163 |
|
H | H |
|
HC=CH | 76.7 | 7.2 |
| 164 |
|
H | H |
|
HC=CH | 63.0 | 23.0 |
| 165 | H | H | H |
|
HC=CH | 71.2 | 5.4 |
| 166 | OCOMe | H | H |
|
HC=CH | 79.1 | 4.8 |
a n.d. = not determined.